Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Portrayal of Hospital Alcohol Detoxification in France (Alcostop)

18 de octubre de 2021 actualizado por: University Hospital, Montpellier

Portrayal of Hospital Alcohol Detoxifications and Factors Associated With Longer or Ulterior Hospitalizations in France From 2011 to 2020

Even if hospital alcohol detoxifications are frequent in France, their caracteristicscharacteristics remain unknown. The investigators aim to describe the clinical and paraclinical caracteristicscharacteristics of their patients, their length and geographical repartition, etc… The investigators also aim to evaluate factors associated with longer stays or ulterior re-hospitalization for the same reason. Finally, The investigators aim to compare the stays by facility type.

Descripción general del estudio

Descripción detallada

Context:

In France, the consequences of excessive alcohol use are one of the primary reasons for hospitalization. When stopping the substance, patients with an alcohol use disorder can suffer from a potentially fatal alcohol withdrawal syndrome. To mitigate these risks, a withdrawal under medical supervision is possible, either in an outpatient setting or in hospital, where the detoxification can be programmed or imposed. In the course of an alcohol dependent patient's life, re-drinking is not exceptional and the patient may undergo several withdrawals during his or her life.

Psychiatric pathologies, especially anxiety and depression, are more frequent in these patients than in the rest of the population, just as can be somatic pathologies.e. Withdrawal accidents, represented by comital seizures and delirium tremens, can be critical.

In hospital detoxifications, studies do not show any benefit in continuing the stay beyond 10 days, except in the case of somatic or psychiatric complication. However, little information is available on the average length of stay for hospital alcohol detoxification.

Although alcohol dependence issues are very frequent and the resulting withdrawals are relatively common and associated with numerous comorbidities, little data exists at a national level in France.

The aim of this study is to describe these hospital detoxifications: course, duration, frequency and clinical and paraclinical characteristics of the patients. We also wish to analyze which characteristics are associated with longer stays or re-hospitalization and to compare the care according to the facility type.

Objectives:

Main:

- To describe the clinical, paraclinical, and stay characteristics of hospital alcohol detoxification in France

Secondary:

  • To describe the regional distribution of hospital alcohol detoxification
  • To evaluate whether certain clinical characteristics are associated with a longer hospital stays
  • To evaluate whether certain clinical characteristics are associated with subsequent re-hospitalization for the same reason
  • To compare the characteristics of patient stays by type of facility

Methods:

In this descriptive observational study using pre-existing data accessed via the PMSI (Programme de Médicalisation des Systèmes d'Information), we will use all hospital stays from 2011 to 2020 for alcohol detoxification in France, both in public and private settings.

For each hospital stay will be collected the length, the antecedents of hospital alcohol detoxification, clinical and psychiatric comorbidities, withdrawals complication, alcohol use complication, further examinations.

We will describe the stays using median and quartiles for continuous variables and number and percentage for dichotomous variables. For secondary objectives, we will use a multivariate linear regression model if the length of stay is normal, an ordinal regression model otherwise. The characteristics of the stays will be compared regarding the type of facility using univariate comparative tests: Chi² or Fisher for dichotomous variables and Student or Mann-Whitney for continuous variables.

Tipo de estudio

De observación

Inscripción (Actual)

50000

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Montpellier, Francia, 34295
        • Uhmontpellier

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

French patients hospitalized for alcohol detoxification from 2011 to 2020

Descripción

Inclusion criteria:

Inclusion criteria:

  • French patients of at least 18 years old
  • Inpatients of a public or private care facility for alcohol detoxification
  • From 01/01/2011 to 12/31/2020
  • In a medical or psychiatric hospital

Exclusion criteria:

- age < 18 years

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Inpatients for alcohol detoxifications
French patients who were hospitalized for alcohol detoxification from 2011 to 2020
Stay for alcohol detoxification : routine care.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
description of age
Periodo de tiempo: day 1 (At hospital inclusion)
Age at admission (in years), calculated by the difference of the year of admission and the year of birth through the PMSI.
day 1 (At hospital inclusion)
description of sex
Periodo de tiempo: day 1 (At hospital inclusion)
Sex collected through the PMSI.
day 1 (At hospital inclusion)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
description of geographic code
Periodo de tiempo: day 1 (At hospital inclusion)
Sex collected through the PMSI.
day 1 (At hospital inclusion)
description of CMU-C
Periodo de tiempo: day 1 (At hospital inclusion)
CMU-C (universal complementary health insurance, collected through the PMSI.
day 1 (At hospital inclusion)
Length of stay
Periodo de tiempo: During the stay (day 1 - day 15)
Length of stay (in days), calculated by the difference between the discharge date and the entry date, collected through the PMSI.
During the stay (day 1 - day 15)
Care establishment
Periodo de tiempo: During the stay (day 1 - day 15)
Name and type of the care establishment, collected through the PMSI.
During the stay (day 1 - day 15)
Number of previous hospital detoxification stays in the studied period
Periodo de tiempo: During the stay (day 1 - day 15)
Number of previous hospital detoxification stays in the studied period, collected through the PMSI.
During the stay (day 1 - day 15)
Psychiatric comorbidities
Periodo de tiempo: During the stay (day 1 - day 15)
Psychiatric comorbidities (Major depression episode, anxiety, psychotic trouble, personality diseases), collected through the PMSI.
During the stay (day 1 - day 15)
Withdrawal complication
Periodo de tiempo: During the stay (day 1 - day 15)
Withdrawal complications (delirium tremens, comitial seizures), collected through the PMSI.
During the stay (day 1 - day 15)
Further examination
Periodo de tiempo: During the stay (day 1 - day 15)
Further examination (biology, imagery, etc…), collected through the PMSI.
During the stay (day 1 - day 15)
Re-hospitalization for same reason
Periodo de tiempo: day 1
For each patient, and each stay, we will evaluate if the patient had an ulterior re-hospitalization for alcohol withdrawal. Collected through the PMSI.
day 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Lionel MOULIS, University Hospital, Montpellier

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de mayo de 2021

Finalización primaria (Actual)

30 de agosto de 2021

Finalización del estudio (Actual)

30 de agosto de 2021

Fechas de registro del estudio

Enviado por primera vez

6 de julio de 2021

Primero enviado que cumplió con los criterios de control de calidad

21 de julio de 2021

Publicado por primera vez (Actual)

22 de julio de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de octubre de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

18 de octubre de 2021

Última verificación

1 de octubre de 2021

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

NC

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir